|

zoledronic acid plus Sintilimab intraperitoneal injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Qilu Hospital of Shandong University1

Indications

  • Ascites, Malignant1
  • Cancer of Stomach, Adenocarcinoma1
  • Cancer1

Other1 trial

Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.